To access this element change to forms mode OFF
Grant Award View - GA58829
Delivering Personalised Medicine for Lung Cancer
GA ID:
GA58829
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$2,682,424.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Delivering Personalised Medicine for Lung Cancer
Purpose:
Lung cancer causes more deaths than any other cancer in Australia or worldwide. The aim of this investigator grant is to develop and evaluate new treatments for lung cancer patients. This will involve a combination of clinical research extending from innovative phase 1 to practice changing phase 3 clinical trials and laboratory based translational research with blood and tissue directed at delivering precision medicine and improving outcomes for patients with lung cancer.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1173450
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA